Pharmacytimes offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Tue, 20 Mar 18 01:48:09 +0000 Tue, 20 Mar 18 01:48:09 +0000 Pharmacist Feature Friday: A Pharmacist's Compassion Inspired Me to Attend Pharmacy School An interaction with passionate pharmacist and co-worker caused E. Ashley Gulyas, PharmD, to enroll in pharmacy school after nearly a decade of work as a pharmacy technician.<br /> &nbsp; Fri, 16 Mar 18 16:33:00 +0000 Pharmacy Owners, Managers Turning to Outside Help to Boost Profits Several pharmacy owners are working with innovative companies that have new products, effective programs, or innovative services that address these issues, and when implemented make it possible to their pharmacy to be profitable.&nbsp; &nbsp;<br /> &nbsp; Wed, 14 Mar 18 14:40:00 +0000 FDA Approves Smart Continuous Glucose Monitoring System Officials with the FDA have approved Medtronic&rsquo;s continuous glucose monitoring (CGM) system (Guardian Connect) for use by individuals living with diabetes, according to a company press release.<br /> &nbsp; Tue, 13 Mar 18 20:48:00 +0000 Pharmacist Feature Friday: Pharmacists Are the Game Changers of Health Care Pharmacists are medication experts who play an integral role in the health care team. I am honored to be a pharmacist and believe that we are lifelong learners. Fri, 09 Mar 18 15:15:00 +0000 CDC: Emergency Department Data Signal Worsening Opioid Epidemic Emergency department (ED) visits in the United States for opioid overdoses are up, signaling that the epidemic is worsening, according to a recent CDC report. Thu, 08 Mar 18 21:33:00 +0000 Cigna and Express Scripts Announce Acquisition Agreement Cigna Corporation and Express Scripts have announced an agreement in which Cigna will purchase the pharmacy benefit manager (PBM) for $67 billion, which includes $15 billion in Express Scripts debt.&nbsp; Thu, 08 Mar 18 17:04:00 +0000 FDA OKs Lurasidone for Use as Bipolar Medication in Children Officials with the FDA have approved a supplemental new drug application (sNDA) to expand the use of lurasidone HCl (Latuda, Sunovion) to include the treatment of bipolar depression in pediatric patients (10 to 17 years of age). Wed, 07 Mar 18 12:00:00 +0000 FDA OKs Direct-to-Consumer Cancer Mutation Test A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.<br /> &nbsp; Tue, 06 Mar 18 17:05:00 +0000 FDA OKs Non-Opioid Pain Patch for Post-Herpetic Neuralgia The FDA approved ZTlido (lidocaine topical system) 1.8% for the treatment of pain associated with post-herpetic neuralgia (PHA), which is caused by shingles. Wed, 28 Feb 18 21:37:00 +0000 Pharmacy Times, Specialty Pharmacy Times Launch Pharmacist Feature Friday Pharmacists can submit photos and captions to be featured on social media. Tue, 27 Feb 18 17:10:00 +0000 The Role of Pharmacy Benefit Mangers in American Health Care: Pharmacy Concerns and Perspectives: Part 3 There have been multiple concerns levied about PBM tactics that have led plan sponsors and pharmacy stakeholders to push back. Mon, 26 Feb 18 10:54:00 +0000 FDA Approves Short-Term Acute Pain Management Drug Kempharma introduces newly approved pain management drug and warns of risk for addiction. Sat, 24 Feb 18 13:00:00 +0000 Arkansas Pharmacists, Legislators Call for Pharmacy Benefits Manager Licenses Pharmacy benefit managers would be required to obtain a license from the state to do business in Arkansas, under proposed legislation announced Wednesday.&nbsp; Wed, 21 Feb 18 22:24:00 +0000 FDA Tentatively OKs Fixed-Dose HIV Combo Therapy Under the PEPFAR program, the antiretroviral (ARV) combination will be available in developing countries as a treatment for patients with HIV/AIDS. Wed, 21 Feb 18 07:58:00 +0000 What to Know About Working with PBMs A Pharmacy Benefit Manager (PBM) is a third party administrator contracted by health plans, employers, unions and government entities to manage prescription drug programs.&nbsp;A PBM acts as a fiscal intermediary between insurers/payors and pharmacies. Tue, 20 Feb 18 18:32:00 +0000 Understanding, Managing Immunotherapy Side Effects Immunotherapy-related side effects can occur at any time and can affect any organ. Mon, 19 Feb 18 16:41:00 +0000 Durvalumab Approved by FDA for Reducing NSCLC Progression The FDA recently approved durvalumab (Imfinzi) for the treatment of patients with stage 3 non-small cell lung cancer (NSCLC) whose tumors are unresectable and whose disease has not progressed following treatment with chemoradiation. Mon, 19 Feb 18 16:16:00 +0000 Breath-Actuated Aerosol for Asthma Maintenance Launches QVAR RediHaler is now commercially available to patients by prescription in 40 mcg and 80 mcg strengths. Sat, 17 Feb 18 11:55:00 +0000 New Prostate Cancer Drug Gets FDA OK Wed, 14 Feb 18 22:35:00 +0000 FDA OKs Combo Treatment for Cystic Fibrosis Caused by Certain Mutations FDA officials have approved tezacaftor/ivacaftor and ivacaftor (Symdeko, Vertex Pharmaceuticals) for the treatment of cystic fibrosis (CF) in individuals aged 12 years and older. Tue, 13 Feb 18 19:18:00 +0000 FDA Approves Generic Drug for Relapsing Multiple Sclerosis Officials with the FDA have approved Novartis&#39;&nbsp;glatiramer acetate injection (Glatopa) 40-mg/mL for the treatment of multiple sclerosis (MS). Tue, 13 Feb 18 14:28:00 +0000 Threat of Drug-Resistant E coli Increases with Pediatric Antibiotic Prescriptions Antibiotics may become ineffective in treating <em>E coli</em> if antibiotic resistance continues to increase among children. Mon, 12 Feb 18 14:00:00 +0000 Pharmacists Remain Among Most Trusted and Ethical Professionals Pharmacists have once again been ranked among the most honest and ethical professionals in the United States, according to the results of the latest Gallup poll on the topic. Fri, 09 Feb 18 14:00:00 +0000 QR Codes Make Their Way to Prescription Drugs An innovate production method may allow health care providers to produce on-demand medicine in the near future.<br /> &nbsp; Fri, 09 Feb 18 13:00:00 +0000 FDA Approves Castration-Sensitive Prostate Cancer Drug Officials with the FDA have granted approval to abiraterone acetate (Zytiga) tablets in combination with&nbsp;prednisone for the treatment of metastatic high-risk castration-sensitive prostate cancer (CSPC), according to a press release. Thu, 08 Feb 18 21:18:00 +0000